Introduction
Some of the most profound insights in developmental biology have come from genetic analyses of mutations in Drosophila, C. elegans, yeast, and E coli. Genetic analysis of the developing mammalian nervous system has been difficult because of the large size of the genome, long times to maturity and the inability to select for genes using classical genetic methods. Even when spontaneous mutations affecting the nervous system are available and well characterized phenotypically, the underlying genetic defects have remained unknown. Since recognition of these mutations requires observations of affected individuals, many mutations affecting the nervous system that are embryonic lethals have gone undetected. A new strategy now allows systematic genetic analysis of the processes underlying development of the mammalian nervous system, including neurogenesis, segmentation, lineage, cell survival, cell death, cell adhesion, axon guidance, and synaptogenesis.
This new strategy utilizes homologous recombination or gene targeting in pluripotent mouse embryonic stem (ES) cells to replace the wild type gene with a portion of a cloned gene that has been altered in vitro (Capecchi 1989 , Evans 1989 , Bradley 1990 , Robertson 1991 , Zimmer 1992 . Typically, a 4-10 Kb piece of genomic DNA containing one or more of the exons of a gene is altered in vitro to create a replacement vector by inserting a dominant selectable marker, such as the neomycin resistance gene, into one of the exons and by placing a flanking thymidine kinase gene at the end of the cloned sequence of DNA.The replacement vector is introduced into pluripotent mouse embryonic stem cells (ES cell) by electroporation (Fig. 1) . If the replacement vector finds its cognate sequence among the 3 x 10 9 nucleotide bases in a mouse ES cell, a homologous recombination event occurs in which the homologous sequence containing the neomycin resistant gene replaces the wild type sequence. The neomycin resistant gene provides a means for selecting G418 antibiotic resistant ES cells that have incorporated the replacement vector and for disrupting the coding region of the target gene. The thymidine kinase (tk) gene of herpes simplex virus selects against nonhomologous recombination events. Treatment of cells with gancyclovir or FIAU kills ES cells harbouring random insertions expressing the tk gene and results in a 2-to 50-fold enrichment in homologous recombination events.
Following positive selection with G418 and negative selection with gangcyclovir or FIAU, ES cell colonies form (Fig. 1) .These colonies are expanded for Southern analysis. Detection of a change in the size of a restriction fragment, by probing a Southern blot with a flanking probe, confirms that a homologous recombination event has occurred. The frequency of detecting a homologous recombination event is highly locus dependent, but, typically, 1 in 30 ES cell colonies that have undergone positive-negative selection show a gene conversion event.
The ES cell line derived from an sv/129 agouti mouse with the targeted mutation is then introduced into a 3.5-day-old C57/B16 mouse embryo by injection. The offspring are mouse chimeras in which portions of the progeny are derived from the mutant clone and from the host embryo. Brown and black coat chimerism provides a marker for germ line transmission of the targeted mutation. If the mutant pluripotent embryonic stem cell has colonized and become part of the germline of the chimera, then mating the male chimera with a wild type C57/B16 mouse will generate an agouti mouse since agouti is dominant over black. These agouti offspring are heterozygous for the targeted mutation. By making the appropriate crosses, homozygous animals can be produced and their phenotypes characterized.
This strategy provides an opportunity to knockout any cloned gene in mice and offers a powerful tool to analyse the importance of specific gene products in the ontogeny of the nervous system. Neural development can be generally divided into four periods (Joyner & Guillemot 1994) : induction of the neuroepithelium, pattern formation, neurogenesis and the determination of cell fate, and terminal differentiation of specific cell types and the formation of synapses. This review discusses studies using gene targeting to alter the last three stages of development of the murine nervous system.
